Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.76% |
| 2 | Technology | 8.34% |
| 3 | Healthcare | 6.09% |
| 4 | Financials | 5% |
| 5 | Consumer Discretionary | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
3876
DELISTED
SpringWorks Therapeutics
SWTX
| $1.25M | ﹤0.01% |
34,205
-80,718
| -70% | -$2.11M |
|
|
NSTG
3877
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.25M | ﹤0.01% |
1,665,199
+564,731
| +51% | +$597K |
|
3878
Camden National
CAC
$957M
| $1.24M | ﹤0.01% |
33,071
-16,742
| -34% | -$546K |
|
3879
Designer Brands
DBI
$279M
| $1.24M | ﹤0.01% |
140,617
+3,890
| +3% | +$40.9K |
|
3880
Turkcell
TKC
$4.7B
| $1.24M | ﹤0.01% |
258,663
+122,576
| +90% | +$576K |
|
|
PGRE
3881
DELISTED
Paramount Group
PGRE
| $1.24M | ﹤0.01% |
240,379
-29,233
| -11% | -$139K |
|
|
GBIO
3882
DELISTED
Generation Bio
GBIO
| $1.24M | ﹤0.01% |
75,275
+72,208
| +2,354% | +$1.26M |
|
3883
Bioventus
BVS
$945M
| $1.24M | ﹤0.01% |
235,483
-104,693
| -31% | -$414K |
|
3884
PUT
Avis
CAR
$4.88B
| $1.24M | ﹤0.01% |
7,000
-11,400
| -62% | -$2.08M |
|
3885
CALL
OneMain Financial
OMF
$7.23B
| $1.24M | ﹤0.01% |
+25,200
| New | +$1.03M |
|
|
3886
PUT
OneMain Financial
OMF
$7.23B
| $1.24M | ﹤0.01% |
25,200
-74,800
| -75% | -$3.05M |
|
3887
CALL
Baxter International
BAX
$13.5B
| $1.24M | ﹤0.01% |
+32,000
| New | +$1.13M |
|
|
BRSP
3888
BrightSpire Capital
BRSP
$601M
| $1.23M | ﹤0.01% |
165,551
-56,038
| -25% | -$366K |
|
3889
Eagle Materials
EXP
$6.06B
| $1.23M | ﹤0.01% |
6,071
-5,750
| -49% | -$1.01M |
|
3890
CytomX Therapeutics
CTMX
$699M
| $1.23M | ﹤0.01% |
794,047
+95,141
| +14% | +$125K |
|
3891
ANI Pharmaceuticals
ANIP
$1.67B
| $1.23M | ﹤0.01% |
+22,300
| New | +$1.23M |
|
3892
PUT
Molina Healthcare
MOH
$10.4B
| $1.23M | ﹤0.01% |
3,400
-2,800
| -45% | -$988K |
|
3893
Highwoods Properties
HIW
$3.44B
| $1.23M | ﹤0.01% |
53,450
-496,945
| -90% | -$9.9M |
|
|
SILK
3894
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.23M | ﹤0.01% |
+100,000
| New | +$938K |
|
3895
Brink's
BCO
$4.57B
| $1.23M | ﹤0.01% |
13,932
-14,786
| -51% | -$1.14M |
|
3896
PUT
Virgin Galactic
SPCE
$446M
| $1.23M | ﹤0.01% |
+25,000
| New | +$987K |
|
3897
Olema Pharmaceuticals
OLMA
$899M
| $1.22M | ﹤0.01% |
87,252
-126,842
| -59% | -$1.7M |
|
3898
PUT
Synaptics
SYNA
$3.72B
| $1.22M | ﹤0.01% |
10,700
+6,000
| +128% | +$596K |
|
3899
PUT
First Horizon
FHN
$11.7B
| $1.22M | ﹤0.01% |
86,100
-466,700
| -84% | -$5.62M |
|
|
CSR
3900
Centerspace
CSR
$881M
| $1.22M | ﹤0.01% |
20,947
+12,226
| +140% | +$668K |
|
Similar funds
Israel Englander's Q4 2023 Portfolio in Review
As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander's Q4 2023 filing shows 816 new, 2,304 increased, 2,388 reduced and 883 closed positions. Its largest new stake was Ferguson: 906,589 shares worth $175M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Israel Englander opened 816 new positions and closed 883 in Q4 2023.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.